Commentary|Podcasts|November 27, 2024
Nov. 27 is Here: What Does That Mean for DSCSA?
Author(s)Nicholas Saraceno, Editor
Nicholas Saraceno offers an overview of the legislation and how it impacts the pharma supply chain.
Advertisement
In this episode of The PC Podcast, Nicholas Saraceno, Pharma Commerce’s editor, explains:
- The history behind the Drug Supply Chain Security Act (DSCSA)
- The significance of Nov. 27
- The latest DSCSA exemptions and what that means for trading partners
- How this piece of legislation and AI are able to intertwine
The latest episode of The Pharmaceutical Commerce Podcast is available directly on
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
Cencora Accelerates Global 3PL Expansion With Major Investments in Cold Chain and Specialty Logistics
3
What MFN Pricing Means for Future Drug Development
4
Pharma Pulse: Pazdur Retires from FDA, While Public Trusts AMA Over CDC on Vaccines, and New Data Redefines Adherence as an Emotional Crisis
5
